1. Home
  2. CGEN vs BHR Comparison

CGEN vs BHR Comparison

Compare CGEN & BHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$1.74

Market Cap

220.7M

Sector

Health Care

ML Signal

HOLD

BHR

Braemar Hotels & Resorts Inc.

HOLD

Current Price

$2.97

Market Cap

195.8M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGEN
BHR
Founded
1993
2013
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
220.7M
195.8M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
CGEN
BHR
Price
$1.74
$2.97
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
568.8K
403.7K
Earning Date
03-03-2026
02-26-2026
Dividend Yield
N/A
6.64%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,903,000.00
$710,399,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$164.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.13
$1.80
52 Week High
$2.66
$3.28

Technical Indicators

Market Signals
Indicator
CGEN
BHR
Relative Strength Index (RSI) 42.09 54.89
Support Level $2.04 $2.64
Resistance Level $2.08 $3.13
Average True Range (ATR) 0.12 0.14
MACD -0.05 -0.00
Stochastic Oscillator 1.00 57.66

Price Performance

Historical Comparison
CGEN
BHR

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About BHR Braemar Hotels & Resorts Inc.

Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury, upper-upscale and upscale hotels in gateway and resort locations. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.

Share on Social Networks: